Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Jun 2012 Status changed from recruiting to completed as reported in Diabetes Care.
- 14 Jun 2012 Results published in Diabetes Care.
- 13 Sep 2011 Planned end date changed from Sep 2011 to Sep 2012 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History